Department of Anaesthesia, Manchester Royal Infirmary, Oxford Road, Manchester, Lancashire, UK.
Eur J Anaesthesiol. 2010 Mar;27(3):226-32. doi: 10.1097/EJA.0b013e3283308e7f.
The objective of this review is to provide an comprehensive overview of the evolution of acute respiratory distress syndrome (ARDS) in cellular, animal and human models with specific reference to sepsis and haemorrhage. Within this work we have attempted to describe the temporal evolution of the disease process.ARDS is a complication of pulmonary and systemic disease and it can follow sepsis or haemorrhage. The definition of this condition states an acute onset and this review seeks to clarify the time course of that onset following sepsis and haemorrhage. The underlying pathophysiological mechanisms include activation of the immune response, neutrophil activation and sequestration of these into the alveolus with subsequent tissue damage and hypoxia.
The biological evolution of these processes from sepsis or haemorrhage has been well described and the earliest measurable changes in the process occur within 15 min with the clinical manifestations of the syndrome occurring within 12 h. The rapid development of this condition should be considered during the treatment of haemorrhagic or septic shock.
本综述的目的在于提供一个全面的概述,阐述细胞、动物和人类模型中急性呼吸窘迫综合征(ARDS)的演变,特别是关于脓毒症和出血。在这项工作中,我们试图描述疾病过程的时间演变。ARDS 是肺部和系统性疾病的并发症,它可能继发于脓毒症或出血。该病症的定义为急性发作,本综述旨在阐明继脓毒症和出血后该发作的时间进程。潜在的病理生理学机制包括免疫反应的激活、中性粒细胞的激活和这些细胞在肺泡中的隔离,随后导致组织损伤和缺氧。
这些过程从脓毒症或出血到 ARDS 的生物学演变已经得到了很好的描述,最早可测量的变化发生在 15 分钟内,而综合征的临床表现发生在 12 小时内。在治疗出血性或感染性休克时,应考虑到这种情况的快速发展。